Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash	$ 264,840	$ 247,862
Accounts receivable, net of allowance for doubtful accounts of $0 and $66,000, respectively		1,032,886
Other current assets	12,305	5,934
Total current assets	277,145	1,286,682
Patents, net of accumulated amortization of $715,519 and $2,266,158, respectively	539,481	2,200,959
Total assets	816,626	3,487,641
Current liabilities
Accounts payable and accrued liabilities	129,426	2,892,025
Loans payable	138,000	147,000
Purchase price of patents, current portion		1,500,000
Funding Liability	3,202,765
Loan payable – related party	2,805,000	4,672,810
Warrant liability	1,636,187
Accrued interest	491,971	284,885
Total current liabilities	8,403,349	9,496,720
Non-current liabilities
Loan payable - SBA	150,000	174,392
Purchase price of patents, net of unamortized discount of $0 and $131,793, respectively	190,000	658,207
Total liabilities	8,743,349	10,329,319
Stockholders’ deficit
Preferred stock, par value $0.00003 per share – authorized 10,000,000 shares – no shares issued and outstanding
Common stock, par value $0.00003 per share; authorized 10,000,000,000 at December 31, 2021 and 2020; shares issued and outstanding 533,334,630 and 383,038,334 at December 31, 2021 and 2020, respectively	16,000	11,491
Additional paid-in capital	17,493,027	14,427,782
Accumulated deficit	(25,435,978)	(21,281,179)
Total Quest Patent Research Corporation stockholders’ deficit	(7,926,951)	(6,841,906)
Non-controlling interest in subsidiary	228	228
Total stockholders’ deficit	(7,926,723)	(6,841,678)
Total liabilities and stockholders’ deficit	$ 816,626	$ 3,487,641